Lastly, it is worth noting that MDM2 or CDK4 amplification is not exclusive to mesenchymal neoplasms; this genetic alteration has also been observed in other epithelial neoplasms or melanomas [98,99,100]. This evidence concerns the gene MDM2 and mesenchymal cell neoplasm.